Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer

Clinical trial NCT03238495 · UNKNOWN

Trial details

NCT number: NCT03238495
Sponsor: Qamar Khan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2017-08-15
Primary completion: 2022-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.